Skip to main content
. 2015 May 7;13:148. doi: 10.1186/s12967-015-0504-2

Figure 1.

Figure 1

miR-572 expression level in serum of MS patients and controls. miR-572 relative expression fold change (ref: C. el. miR-39) in serum of MS patients and healthy controls (HC) (panel A) and of MS patients with different disease phenotypes, using as reference C. el miR-39 (panel B), miR-103 (panel C) and miR-423 (panel D). Analyses reported in panel C and D were performed on a subgroup of subjects. PPMS = primary progressive MS; SPMS = secondary progressive MS; RRMS = relapsing-remitting MS. Bars represent the median values; statistical significance is shown.